PuSH - Publication Server of Helmholtz Zentrum München

Barbosa-Yañez, R.L.* ; Markova, M.* ; Dambeck, U.* ; Honsek, C.* ; Machann, J. ; Schüler, R.* ; Kabisch, S.* ; Pfeiffer, A.F.H.*

Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects.

Peptides 125:170237 (2020)
Postprint DOI PMC
Open Access Green
The gastric inhibitory polypeptide receptor (GIPR) regulates postprandial metabolism. In this context GIPR SNP rs10423928 seems toplay an important role in modulating glucose metabolism and insulinsensitivity. However, evidence regarding thisparticular SNP is still vague.In this study, we collected baseline data from four different dietaryintervention studies. We genotyped 424 subjects with prediabetes and 73with diabetes for GIPR SNP rs10423928 and examined its impact on glucosemetabolism, insulin sensitivity and body fat accumulation.We extended previous data by showing that carriers of the A allele withprediabetes displayed increased fasting glucose (p = 0.015). Unexpectedly,A allele carriers showed lower glucose levels 2 h (p = 0.021) after anoral glucose challenge compared to T/T homozygous individuals. A allelecarriers also showed significantly higher insulin sensitivity (p < 0.001)(assessed by Cederholm Index), indicating an enhanced beta-cell response.This study points to a potential protective role for rs10423928 inglucose metabolism and insulin sensitivity in subjects with prediabetes.Further studies are necessary to confirm these results.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
2.843
0.824
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Glucose-dependent Insulinotropic Peptide ; Gipr ; Glucose Metabolism ; Insulin Sensitivity ; Prediabetes ; Diabetes; Dependent Insulinotropic Polypeptide; Physiological Characterization; Receptor; Tissue; Expression; Resistance; Cloning; Inhibition; Responses; Release
Language english
Publication Year 2020
Prepublished in Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 0196-9781
e-ISSN 1873-5169
Journal Peptides
Quellenangaben Volume: 125, Issue: , Pages: , Article Number: 170237 Supplement: ,
Publisher Elsevier
Publishing Place New York, NY
Reviewing status Peer reviewed
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
Scopus ID 85077357482
PubMed ID 31874232
Erfassungsdatum 2020-01-20